Zhen Zhou Selected Research

Zhen Zhou Research Topics

Disease

50	Neoplasms (Cancer) 11/2022 - 01/2012
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 09/2008
15	Inflammation (Inflammations) 10/2022 - 06/2015
12	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 06/2009
12	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2008
11	Fibrosis (Cirrhosis) 01/2022 - 10/2016
8	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2008
8	Infections 06/2021 - 12/2006
7	COVID-19 09/2022 - 01/2020
7	Breast Neoplasms (Breast Cancer) 09/2021 - 01/2018
7	Reperfusion Injury 01/2020 - 10/2013
6	Carcinoma (Carcinomatosis) 01/2022 - 01/2017
5	Myocardial Infarction 11/2022 - 06/2009
5	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 01/2017
5	Stomach Neoplasms (Stomach Cancer) 08/2021 - 10/2017
5	Adenocarcinoma of Lung 05/2020 - 09/2008
5	Ischemia 09/2019 - 01/2015
4	Atherosclerosis 10/2022 - 08/2015
4	Hypertension (High Blood Pressure) 10/2022 - 01/2017
4	Dementia (Dementias) 10/2021 - 09/2011
4	Lung Injury 11/2020 - 01/2015
4	Carcinogenesis 02/2018 - 01/2015
3	Cardiotoxicity 06/2022 - 01/2021
3	Pain (Aches) 06/2022 - 01/2017
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2019
3	Heart Failure 01/2022 - 06/2009
3	Osteoporosis 01/2022 - 02/2019
3	Epilepsy (Aura) 02/2021 - 08/2012
3	Sepsis (Septicemia) 11/2020 - 12/2017
3	Aortic Dissection 04/2017 - 05/2012
2	Hemorrhage 09/2022 - 12/2006
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 09/2022 - 12/2017
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2022 - 01/2016
2	Idiopathic Pulmonary Fibrosis 05/2022 - 01/2019
2	Hypertrophy 04/2022 - 06/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2022
2	Adenocarcinoma 01/2022 - 01/2020
2	Cognitive Dysfunction 10/2021 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 06/2021 - 02/2018
2	Cardiomegaly (Heart Hypertrophy) 06/2021 - 06/2009
2	Hypoxia (Hypoxemia) 05/2021 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 08/2015
2	Leukemia 01/2021 - 01/2012
2	Fever (Fevers) 05/2020 - 01/2017
2	Body Weight (Weight, Body) 03/2020 - 08/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 10/2017

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 10/2022 - 09/2011
17	MicroRNAs (MicroRNA)IBA 06/2022 - 06/2009
15	Messenger RNA (mRNA)IBA 10/2022 - 02/2011
13	Biomarkers (Surrogate Marker)IBA 11/2022 - 04/2012
8	Pharmaceutical PreparationsIBA 06/2022 - 01/2012
8	RNA (Ribonucleic Acid)IBA 05/2022 - 01/2015
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022 - 09/2017
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2012
6	Biological ProductsIBA 06/2021 - 01/2015
6	CytokinesIBA 09/2019 - 01/2015
5	Long Noncoding RNAIBA 04/2022 - 01/2019
5	Therapeutic UsesIBA 11/2020 - 01/2012
4	Tyrosine Kinase InhibitorsIBA 11/2022 - 09/2017
4	LipidsIBA 10/2022 - 12/2020
4	CholesterolIBA 10/2022 - 07/2009
4	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2017
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2022 - 01/2020
4	Circular RNAIBA 06/2022 - 10/2021
3	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 10/2022 - 01/2020
3	oxidized low density lipoproteinIBA 10/2022 - 12/2020
3	Triglycerides (Triacylglycerol)IBA 10/2022 - 11/2019
3	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2019
3	PlatinumIBA 01/2022 - 01/2010
3	Phosphotransferases (Kinase)IBA 01/2022 - 12/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 02/2011
3	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 04/2019
3	ErbB Receptors (EGF Receptor)IBA 09/2021 - 09/2017
3	Caspase 3 (Caspase-3)IBA 01/2021 - 11/2013
3	CollagenIBA 04/2019 - 10/2016
3	Heme Oxygenase-1IBA 10/2017 - 01/2015
2	AdiponectinIBA 11/2022 - 01/2020
2	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 01/2022
2	Sirtuin 1IBA 06/2022 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 05/2022 - 09/2019
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 12/2017
2	CateninsIBA 06/2021 - 01/2017
2	LigandsIBA 05/2021 - 01/2021
2	Docetaxel (Taxotere)FDA Link 01/2021 - 01/2010
2	pembrolizumabIBA 01/2021 - 01/2021
2	EnzymesIBA 03/2020 - 01/2020
2	Alanine Transaminase (SGPT)IBA 03/2020 - 01/2017
2	Collagen Type III (Type III Collagen)IBA 03/2020 - 04/2019
2	Lysine (L-Lysine)FDA Link 01/2020 - 01/2019
2	Angiotensin IIIBA 01/2020 - 04/2017

Therapy/Procedure

24	Therapeutics 01/2022 - 09/2008
12	Drug Therapy (Chemotherapy) 01/2022 - 01/2010
3	Immunotherapy 01/2022 - 05/2021
3	Aftercare (After-Treatment) 01/2021 - 10/2013
3	Oral Administration 01/2021 - 01/2012
3	Punctures 11/2020 - 01/2018
3	Ligation 11/2020 - 10/2015
2	Artificial Respiration (Mechanical Ventilation) 04/2021 - 11/2020